{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:07:28Z","timestamp":1793563648959,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6112,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.fertnstert.2005.02.053","type":"journal-article","created":{"date-parts":[[2005,9,17]],"date-time":"2005-09-17T11:12:00Z","timestamp":1126955520000},"page":"555-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr"],"prefix":"10.1016","volume":"84","author":[{"given":"Murat","family":"Arslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Mirkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel","family":"Stadtmauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Oehninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2005.02.053_bib1","unstructured":"Centers for Disease Control and Prevention. 2001 Assisted Reproductive Technology (ART) Report: Assisted Reproductive Technology and Success Rates. Accessed June 25, 2005. Available at: http:\/\/www.cdc.gov\/reproductivehealth\/ART01\/index.htm"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/oxfordjournals.humrep.a137323","article-title":"Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome","volume":"6","author":"Toner","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/humrep\/12.3.548","article-title":"Cryopreservation","volume":"12","author":"Jones","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0015-0282(16)47473-X","article-title":"Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women","volume":"40","author":"Ferraretti","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1210\/jcem-59-1-178","article-title":"The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human","volume":"59","author":"Jones","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(16)60077-8","article-title":"The value of basal and\/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome","volume":"50","author":"Muasher","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(16)60615-5","article-title":"Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome","volume":"51","author":"Scott","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0015-0282(16)54249-6","article-title":"Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age","volume":"55","author":"Toner","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib9","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0015-0282(16)57974-6","article-title":"Prognostic value of day 3 estradiol on in vitro fertilization outcome","volume":"64","author":"Smotrich","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0015-0282(16)57916-3","article-title":"Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization","volume":"64","author":"Licciardi","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(87)92439-1","article-title":"Prognostic assessment of female fecundity","volume":"2","author":"Navot","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0015-0282(16)53283-X","article-title":"Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization","volume":"53","author":"Padilla","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0015-0282(97)81865-1","article-title":"Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome","volume":"67","author":"Seifer","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0015-0282(16)57979-5","article-title":"Ovarian volume","volume":"64","author":"Syrop","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0029-7844(96)00316-X","article-title":"Relationship of ovarian stromal blood flow at the baseline ultrasound scan to subsequent follicular response in an in vitro fertilization program","volume":"88","author":"Zaidi","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/humrep\/12.2.220","article-title":"Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization","volume":"12","author":"Tomas","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.fertnstert.2003.11.045","article-title":"Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening","volume":"82","author":"Jain","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0015-0282(16)48678-4","article-title":"The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization","volume":"44","author":"Muasher","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0015-0282(16)59239-5","article-title":"Cumulative ovulation rate in human menopausal\/human chorionic gonadotropin-treated monkeys","volume":"47","author":"Abbasi","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib21","series-title":"Current practices and controversies in assisted reproduction","first-page":"102","article-title":"Ovarian stimulation for assisted reproductive technologies","author":"Hugues","year":"2002"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0015-0282(99)00090-4","article-title":"Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization","volume":"71","author":"Enskog","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib24","first-page":"1009","article-title":"Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents","volume":"81","author":"Sher","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0015-0282(16)48550-X","article-title":"The effect of follicle-stimulating hormone without additional luteinizing hormone on follicular stimulation and oocyte development in normal ovulatory women","volume":"43","author":"Jones","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib26","first-page":"CD002811","article-title":"\u201cCoasting\u201d (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome","volume":"3","author":"D\u2019Angelo","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/humrep\/17.2.310","article-title":"The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles","volume":"17","author":"Ulug","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib29","first-page":"CD002806","article-title":"Embryo freezing for preventing ovarian hyperstimulation syndrome","volume":"2","author":"D\u2019Angelo","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1472-6483(10)62069-X","article-title":"Infertility therapy-associated multiple pregnancies (births)","volume":"7","author":"Adashi","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib31","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMsa032073","article-title":"Trends in embryo-transfer practice and in outcomes of the use of assisted reproductive technology in the United States","volume":"350","author":"Jain","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/humupd\/3.4.367","article-title":"Culture and selection of viable blastocysts","volume":"3","author":"Gardner","year":"1997","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib33","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1093\/humrep\/14.9.2345","article-title":"Characterization of a top quality embryo, a step towards single-embryo transfer","volume":"14","author":"Van Royen","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib34","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/humrep\/16.9.1900","article-title":"One versus two embryo transfer after IVF and ICSI","volume":"16","author":"Martikainen","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.fertnstert.2003.07.023","article-title":"Single blastocyst transfer","volume":"81","author":"Gardner","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib36","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1210\/jc.2004-0605","article-title":"Gene expression profiles and structural\/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles","volume":"89","author":"Mirkin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0303-7207(00)00355-5","article-title":"Impact of different clinical variables on pregnancy outcome following embryo cryopreservation","volume":"169","author":"Oehninger","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/oxfordjournals.humrep.a137355","article-title":"Controlled preparation of the endometrium with exogenous steroids for the transfer of frozen-thawed pre-embryos in patients with anovulatory or irregular cycles","volume":"6","author":"Muasher","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0015-0282(16)56943-X","article-title":"Transfer of cryopreserved-thawed pre-embryos in a natural cycle or a programmed cycle with exogenous hormonal replacement yields similar pregnancy results","volume":"62","author":"Queenan","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib40","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/humrep\/12.7.1573","article-title":"Cryopreservation of all prezygotes in patients at risk of severe hyperstimulation does not eliminate the syndrome, but the chances of pregnancy are excellent with subsequent frozen-thaw transfers","volume":"12","author":"Queenan","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(16)56933-7","article-title":"The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program","volume":"62","author":"Olivennes","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib42","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.ajog.2004.02.049","article-title":"Potential factors affecting embryo survival and clinical outcome with cryopreserved pronuclear human embryos","volume":"190","author":"Marrs","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)60553-8","article-title":"Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval","volume":"51","author":"Meldrum","year":"1989","journal-title":"Fertil Steril"},{"issue":"Suppl A","key":"10.1016\/j.fertnstert.2005.02.053_bib44","first-page":"74","article-title":"Use of gonadotrophin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilization","volume":"14","author":"Muasher","year":"1992","journal-title":"Clin Ther"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib45","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/oxfordjournals.humrep.a135740","article-title":"A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization","volume":"10","author":"Out","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib46","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/humrep\/12.10.2133","article-title":"Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP)","volume":"12","author":"Bergh","year":"1997","journal-title":"Hum Reprod"},{"issue":"suppl 2","key":"10.1016\/j.fertnstert.2005.02.053_bib47","first-page":"50S","article-title":"Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization","volume":"69","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib48","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/14.10.2442","article-title":"A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP) in a fixed-dose regimen in women undergoing ovarian stimulation","volume":"14","author":"Hoomans","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/humrep\/15.3.520","volume":"15","author":"Frydman","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib50","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/humrep\/15.5.1021","article-title":"Induction of ovulation in women undergoing assisted reproductive techniques","volume":"15","author":"Lenton","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/humrep\/16.2.319","article-title":"HMG is as good as recombinant human FSH in terms of oocyte and embryo quality","volume":"16","author":"Ng","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","article-title":"Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection","volume":"76","author":"Westergaard","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0015-0282(00)01696-4","article-title":"Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome","volume":"75","author":"Strehler","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib54","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.fertnstert.2004.04.026","article-title":"Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles","volume":"82","author":"Gerli","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib55","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/humrep\/14.6.1431","article-title":"Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol","volume":"14","author":"Raga","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/humrep\/15.1.17","article-title":"Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone","volume":"15","author":"De Placido","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/humrep\/deg099","article-title":"Bye-bye urinary gonadotrophins? Recombinant FSH","volume":"18","author":"Gleicher","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0015-0282(16)57734-6","article-title":"Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles","volume":"64","author":"Daya","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib59","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/humrep\/14.9.2207","article-title":"Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction","volume":"14","author":"Daya","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib60","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0015-0282(99)00519-1","article-title":"Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles","volume":"73","author":"Agrawal","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib61","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0015-0282(03)02187-3","article-title":"Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles","volume":"80","author":"van Wely","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib62","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0015-0282(03)02193-9","article-title":"Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction","volume":"80","author":"Daya","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib63","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0015-0282(97)81402-1","article-title":"Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome","volume":"67","author":"Loumaye","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1095\/biolreprod65.3.655","article-title":"Follicle selection in primates","volume":"65","author":"Zeleznik","year":"2001","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib65","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/oxfordjournals.humrep.a138480","article-title":"Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis","volume":"9","author":"Hillier","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib66","first-page":"2659","article-title":"Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome","volume":"84","author":"Filicori","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib67","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","article-title":"Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction","volume":"15","author":"Westergaard","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib68","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/humrep\/16.8.1636","article-title":"Suppression of LH during ovarian stimulation","volume":"16","author":"Balasch","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib69","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0015-0282(02)03157-6","article-title":"The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation","volume":"77","author":"Shoham","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib70","first-page":"1507","article-title":"Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib71","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/humrep\/17.12.3129","article-title":"Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence","volume":"17","author":"Tesarik","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fertnstert.2004.06.050","article-title":"Follicular phase serum levels of LH do not influence delivery rates in IVF cycles down regulated with a GnRH agonist and stimulated with recombinant FSH","volume":"83","author":"Cabrera","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0015-0282(16)53224-5","article-title":"Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone agonist suppression","volume":"53","author":"Edelstein","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib74","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/humrep\/12.9.1886","article-title":"Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone\/human menopausal gonadotrophin combination","volume":"12","author":"Mercan","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1472-6483(10)61726-9","article-title":"Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction","volume":"7","author":"Balasch","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib76","first-page":"114","article-title":"Recombinant and urinary FSH preparations","volume":"4","author":"Oehninger","year":"1999","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib77","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/deg066","article-title":"Clinical evidence for an LH \u2018ceiling\u2019 effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation","volume":"18","author":"Loumaye","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/09513599909167540","article-title":"Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women","volume":"13","author":"Laml","year":"1999","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib79","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2265.2004.02027.x","article-title":"Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation","volume":"60","author":"De Placido","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib80","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1023\/A:1016662100572","article-title":"The effect of exogenous luteinizing hormone (LH) on oocyte viability","volume":"18","author":"Balasch","year":"2001","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib81","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib82","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0015-0282(02)04920-8","article-title":"Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy","volume":"79","author":"Kolibianakis","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib83","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1067\/S0002-9378(03)00489-7","article-title":"The use of gonadotropin-releasing hormone antagonist in a flexible protocol","volume":"189","author":"Mansour","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib84","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/humrep\/deh334","article-title":"The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF\/ICSI","volume":"19","author":"Mochtar","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib85","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib86","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","article-title":"Ovarian stimulation with HMG","volume":"15","author":"Albano","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib87","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib88","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/humrep\/17.4.874","article-title":"GnRH antagonist in assisted reproduction","volume":"17","author":"Al Inany","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib89","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S1472-6483(10)61098-X","article-title":"Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration","volume":"8","author":"Aboulghar","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib90","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/humrep\/14.12.2959","article-title":"Will GnRH antagonists provide new hope for patients considered \u2018difficult responders\u2019 to GnRH agonist protocols?","volume":"14","author":"Craft","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib91","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/humrep\/15.10.2145","article-title":"Addition of GnRH antagonist in cycles of poor responders undergoing IVF","volume":"15","author":"Akman","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib92","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1023\/B:JARG.0000006707.88826.e7","article-title":"Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF","volume":"20","author":"Fasouliotis","year":"2003","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2005.02.053_bib93","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.fertnstert.2004.07.314","article-title":"Luteal estradiol patch\/GnRH-antagonist suppression prior to gonadotropin stimulation improves IVF outcome in poor responders","volume":"82","author":"Dragisic","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib94","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(16)53282-8","article-title":"Gonadotropin suppression with oral contraceptives before in vitro fertilization","volume":"53","author":"Gonen","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/humupd\/dmg007","article-title":"Clinical management of low ovarian response to stimulation for IVF","volume":"9","author":"Tarlatzis","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib96","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0015-0282(98)00333-1","article-title":"Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates","volume":"70","author":"Biljan","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib97","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/BF02066431","article-title":"Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation","volume":"13","author":"Lindheim","year":"1996","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib98","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/humrep\/15.6.1305","article-title":"A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation","volume":"15","author":"Driscoll","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib99","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/humrep\/15.7.1446","article-title":"Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment\u2014recombinant HCG versus urinary HCG","volume":"15","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib100","first-page":"2607","article-title":"Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib101","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1023\/A:1026236726568","article-title":"Factors associated with an optimal pregnancy outcome in an oocyte donation program","volume":"20","author":"Mirkin","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib102","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1023\/A:1024809607966","article-title":"Impact of transabdominal ultrasound guidance on performance and outcome of transcervical uterine embryo transfer","volume":"20","author":"Mirkin","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib103","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/humrep\/12.11.2359","article-title":"Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients","volume":"12","author":"Damario","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib104","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1471-0528.1993.tb15170.x","article-title":"Hypersecretion of luteinising hormone","volume":"100","author":"Balen","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-0528.1985.tb01113.x","article-title":"Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase","volume":"92","author":"Stanger","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib106","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/humrep\/17.12.3016","article-title":"Should patients with polycystic ovary syndrome be treated with metformin? Benefits of insulin sensitizing drugs in polycystic ovary syndrome\u2014beyond ovulation induction","volume":"17","author":"Stadtmauer","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib108","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/humrep\/deh248","article-title":"Metformin treatment before IVF\/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study","volume":"19","author":"Kjotrod","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib109","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF01207730","article-title":"Treatment of low responders","volume":"10","author":"Muasher","year":"1993","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0015-0282(97)81862-6","article-title":"Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol","volume":"67","author":"Schoolcraft","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib111","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/humrep\/14.7.1744","article-title":"A rational approach to the management of low responders in in-vitro fertilization","volume":"14","author":"Karande","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib112","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0015-0282(16)53345-7","article-title":"High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients","volume":"53","author":"Karande","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib113","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1026280508821","article-title":"Treatment-associated serum FSH levels in very poor responders to ovarian stimulation","volume":"20","author":"Saadat","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib114","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0015-0282(16)56700-4","article-title":"Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization","volume":"61","author":"Scott","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib115","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(16)60372-2","article-title":"Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment","volume":"50","author":"Brzyski","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib116","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0015-0282(16)53285-3","article-title":"Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins","volume":"53","author":"Garcia","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib117","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0015-0282(16)54604-4","article-title":"The gonadotropin-releasing hormone agonist stimulation test\u2014a sensitive predictor of performance in the flare-up in vitro fertilization cycle","volume":"56","author":"Winslow","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib118","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0015-0282(98)00040-5","article-title":"Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders","volume":"69","author":"Faber","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib119","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0015-0282(16)54304-0","article-title":"Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women","volume":"55","author":"Hugues","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib120","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/humrep\/14.5.1262","article-title":"Outcome of in-vitro fertilization through natural cycles in poor responders","volume":"14","author":"Bassil","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib121","first-page":"539","article-title":"A prospective evaluation of clomiphene citrate challenge test screening of the general infertility population","volume":"82","author":"Scott","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib122","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0015-0282(16)58159-X","article-title":"An elevated day three follicle-stimulating hormone","volume":"65","author":"Mukherjee","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib123","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1016601110424","article-title":"High FSH:LH ratio and low LH levels in basal cycle day 3","volume":"18","author":"Barroso","year":"2001","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib124","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1472-6483(10)62055-X","article-title":"Chromosomal abnormalities in a series of 6,733 human oocytes in preimplantation diagnosis for age-related aneuploidies","volume":"6","author":"Kuliev","year":"2003","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0015-0282(16)58041-8","article-title":"Use of a specific zona pellucida (ZP) protein 3 antiserum as a clinical marker for human ZP integrity and function","volume":"65","author":"Oehninger","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib126","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1210\/jc.2003-031766","article-title":"Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization","volume":"89","author":"Devroey","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib127","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2003.12.027","article-title":"Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization","volume":"82","author":"Kolibianakis","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib128","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/humrep\/deh409","article-title":"Identification of viable embryos in IVF by non-invasive measurement of amino acid turnover","volume":"19","author":"Brison","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib129","first-page":"101","article-title":"Impact of ovarian hyperstimulation on the luteal phase","volume":"55","author":"Macklon","year":"2000","journal-title":"J Reprod Fertil (Suppl)"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0015-0282(16)47536-9","article-title":"Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin\/human chorionic gonadotropin for in vitro fertilization","volume":"41","author":"Garcia","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib131","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0002-9378(97)70344-2","article-title":"The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation","volume":"176","author":"Kolb","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2005.02.053_bib132","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0015-0282(03)00663-0","article-title":"Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists","volume":"80","author":"Kolibianakis","year":"2003","journal-title":"Fertil Steril"}],"updated-by":[{"DOI":"10.1016\/j.fertnstert.2005.10.012","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000}}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205012574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205012574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T15:50:11Z","timestamp":1666453811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028205012574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":132,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0015028205012574"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.02.053","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2005.02.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}